Hypoglycemia: Physician and Patient Perspectives

AstraZeneca800 enrolled

Overview

The purpose of this study is to assess the burden of hypoglycemia and identify unmet need related to the management of hypoglycemia among Type 2Diabetes Mellitus (T2DM) patients on OADs and/or insulin. This is an observational study which will identify patients with T2DM in an administrative claims database and will link claims data with results of patient and physician surveys concerning hypoglycemia.

Study Type

OBSERVATIONAL

Enrollment

800

Conditions

Type 2 Diabetes Mellitus Hypoglycemia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * T2DM claims diagnosis (algorithm-based) with at least 2 pharmacy claims for an antidiabetic drug * at least 1 HbA1c test recorded during the identification period * continuous enrollment in the health plan for at least 12 months prior to survey date Exclusion Criteria: * Type 1 Diabetes Mellitus * pregnancy or gestational diabetes

Outcomes

Primary Outcomes

prevalence of hypoglycemia and impact of hypoglycemia

Time frame: October 2009-October 2010

Secondary Outcomes

Patient Reported Outcomes of Hypoglycemia (including fear, awareness, behavioral modification and recovery from hypoglycemia)

Time frame: October 2009-October 2010

Treatment adherence and modification related to hypoglycemia, including health status, glycemic control and healthcare utilization

Time frame: October 2009-October 2010

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.